Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells

Data Supplement

Files in this Data Supplement:

  • Supplemental Data -

    Synthesis of compounds 2-75, 1005, 3-52 and 1002

    Supplemental Figure 1 - Effects on cell viability in androgen-sensitive cells